Skip to main content

Table 4 Study measurements in the clinical groups

From: A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection

Clinical group

Controls

(n = 27)

Not Infected (n = 118)

Infected (n = 74)

  
    

Culture positive (n = 41)

Culture Negative (n = 33)

Duration of antibiotic therapy (days)

0

(0,0)

2

(1,3)

5

(5,7)

7

(5,7)

5

(5,7)

sICAM-1 (ng/ml),

165 (130,290)

168

(140,228)

341

(236,554)

P < 0.001

405 (252,666)

P < 0.001

306 (230,484)

P < 0.001

hsCRP(mg/l),

0.1 (0.1,0.4)

0.1

(0.1,0.7)

0.85 (0.3,15.9)

P < 0.001

2.0 (0.7,21.2)

P < 0.001

0.45 (0.1,2.2)

P = 0.012

SAA(mg/l)

0.9 (0.9,1.0)

1.0

(0.9,2.0)

1.5

(0.9,5.8)

P = 0.004

2.0

(1.0-10.0)

P = 0.001

1.0

(0.9,2.0)

P > 0.05

sE-selectin(ng/ml)

71 (51,118)

90

(59,124)

135

(94,192)

P < 0.001

158 (94,207)

P < 0.001

109 (92,184)

P = 0.009

  1. Levels of test measurements in each clinical group and duration of antibiotic therapy is provided. All data quoted as (median, (1st, 3rd quartiles)).
  2. Statistical comparison between infected and not infected groups (Mann Whitney U test). Highly significant elevations (P < 0.001)are highlighted in bold. Control samples not included in statistical analysis.